LATEST

• BUSINESS Eisai, UCL Renew Neuroscience Alliance to 2030
  July 1, 2026

• BUSINESS Asahi Kasei Nabs Japan Rights to Additional Empaveli Indications
  July 1, 2026

• BUSINESS Viatris Eyes Japan Filing This Year for IgAN Drug
  July 1, 2026

• REGULATORY Lower House Clears Immunization Act Revision
  July 1, 2026

• REGULATORY LDP Cautious over Ishin’s GDP-Linked Healthcare Spending Proposal
  July 1, 2026

• BUSINESS Expert Calls for Greater Awareness of LC-FAOD after Dojolvi Debut
  June 30, 2026

• REGULATORY Japan Begins Review of Domestic CGT Seeds with Limited Market Potential
  June 30, 2026

• ORGANIZATION Incubator Led by Ex-Chugai CEO to Seek Govt Support, Raise Private Funds
  June 30, 2026

• REGULATORY Govt Panel Urges 2027 Bill to Expand Secondary Use of Health Data
  June 30, 2026

• BUSINESS Toho Defense Measure Scraped through Shareholder Vote: Report
  June 30, 2026

• BUSINESS Enhertu Snags EU Approval in HER2 Positive Solid Tumors
  June 30, 2026

• BUSINESS Datroway Grabs Positive CHMP Opinion in 1st-Line TNBC
  June 30, 2026

• BUSINESS Tanabe Gets Thai Approval for Diabetes Drug Canalia
  June 30, 2026

• REGULATORY Japan Panel OKs Carvykti’s Earlier Use in Multiple Myeloma
  June 30, 2026

• BUSINESS Kissei Discussing Japan Response after EU Panel Recommends Pulling Tavneos Approval
  June 29, 2026

• REGULATORY Govt to Explore Greater Rewards for Innovative Drugs in Honebuto
  June 29, 2026

• BUSINESS Sanofi Files Venglustat for Gaucher Disease in Japan
  June 29, 2026

• REGULATORY MHLW Starts Technical Review of OTC-Like Drug Charge Exemptions
  June 29, 2026

• REGULATORY Takeda to Shift Immunoglobulin Production to 10% Formulation
  June 29, 2026

• REGULATORY Japan’s Immunoglobulin Self-Sufficiency Rate Falls Below 60%
  June 29, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »